• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch
Shop

Toronto Board of Health Votes to Decriminalize Drugs

Jason Najum by Jason Najum
December 7, 2021
in Law & Politics
Reading Time: 2 mins read
A A
Toronto Board of Health Votes to Decriminalize Drugs

The city of Toronto has officially voted to decriminalize drugs.

This is the follow-up to last week’s news of a report from Toronto’s Medical Officer of Health recommending that the city should formally apply for the federal exemption to decriminalize possession of small amounts of illegal drugs in Toronto. Last week’s news also showed a serious move up the levels of bureaucracy, with city-wide decrim being supported by both the Toronto police chief, the national association of police chiefs, and Mayor John Tory.

So after months of hard work and public lobbying, yesterday we got the final vote — and Toronto’s Board of Health voted unanimously to request that the federal government give Toronto the right to decriminalize the possession of small amounts of drugs.

The board has requested that the city’s medical officer submit an application to Health Canada for an exemption under the Controlled Drugs and Substances Act. This is the final step from the city’s end — a major achievement to get city-wide support. The final decision now rests with the federal government.

[bsa_pro_ad_space id=2]
ADVERTISEMENT
Buy Lasix Stock

Toronto joins Vancouver as Canadian cities that’ve requested this exemption.

Continue on your trip...

Psylutions and the DEA

US Congress Adds Psychedelics Studies to Defense Bill

Enveric Granted US Patent for Psilocybin Derivatives

The decrim movement just took another solid step forward. Stay tuned.

 

Check out these links for more decrim news: Breaking News: City of Toronto to Vote on Decriminalization and Detroit Decriminalizes Psychedelics

[bsa_pro_ad_space id=2]
ADVERTISEMENT
Tags: Decriminalization
Jason Najum

Jason Najum

Jason Najum's work has appeared in many industry-leading publications, covering topics ranging from cleantech start-ups to travel and culture. He's currently Microdose's Managing Editor and Senior Writer. Write him at jason@microdose.buzz and see his work at www.jasonnajum.com

Next Post

Science Feature: A Look at the 5HT-2A Receptor

Please login to join discussion

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.